Cargando…
Understanding barriers to medication, dietary, and lifestyle treatments prescribed in polycystic kidney disease
BACKGROUND: Autosomal dominant polycystic kidney disease (PKD) is the most common genetic renal disease and the fourth leading cause of end-stage renal disease in the United States. Although there is no cure for PKD, several treatments are considered to be beneficial, including blood pressure contro...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498983/ https://www.ncbi.nlm.nih.gov/pubmed/28679364 http://dx.doi.org/10.1186/s12882-017-0641-3 |
_version_ | 1783248389454954496 |
---|---|
author | Tran, Wen-Ching Huynh, David Chan, Tea Chesla, Catherine A. Park, Meyeon |
author_facet | Tran, Wen-Ching Huynh, David Chan, Tea Chesla, Catherine A. Park, Meyeon |
author_sort | Tran, Wen-Ching |
collection | PubMed |
description | BACKGROUND: Autosomal dominant polycystic kidney disease (PKD) is the most common genetic renal disease and the fourth leading cause of end-stage renal disease in the United States. Although there is no cure for PKD, several treatments are considered to be beneficial, including blood pressure control, exercise, low-salt diet, and high volume water intake. However, levels of understanding of the importance of these treatments and adherence to these recommendations vary among patients. This study explores illness perception models of patients with PKD to reveal barriers in adherence to prescribed therapies; satisfaction with medical care; and sources of medical information. METHODS: We designed a phenomenological interview study to evaluate illness perception models of individuals with PKD. Patients were identified from the national PKD Foundation e-mail distribution list (N = 190) and responded voluntarily to an introductory survey (N = 50). Seventeen PKD patients in the Bay Area were scheduled for one-on-one in-depth interviews with one trained interviewer (W-CT). Open-ended questions administered with an interview guide were used to evaluate patients’ beliefs. RESULTS: Mean age was 56.6 +/− 12 years (range 29–78); 65% were female. Many of the PKD patients in this study were highly motivated and willing to incorporate blood pressure, exercise, low-salt diet, and high volume water intake into their daily routines. Barriers to adherence to these therapies include personal beliefs and confusion due to unclear recommendations. CONCLUSIONS: These findings suggest there is variability between what patients understand about their disease and treatments and what they believe their doctors have told them. Not all physicians focus on lifestyle-based treatments, but the majority of PKD patients in our study are motivated and willing to incorporate blood pressure control, exercise, low-salt diet, and high volume water intake into their daily routines and would like specific recommendations on how to implement these. These findings support a role for further exploring patient beliefs about the disease and its necessary treatments in order to design strategies to improve communication and meet the needs of these patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12882-017-0641-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5498983 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54989832017-07-10 Understanding barriers to medication, dietary, and lifestyle treatments prescribed in polycystic kidney disease Tran, Wen-Ching Huynh, David Chan, Tea Chesla, Catherine A. Park, Meyeon BMC Nephrol Research Article BACKGROUND: Autosomal dominant polycystic kidney disease (PKD) is the most common genetic renal disease and the fourth leading cause of end-stage renal disease in the United States. Although there is no cure for PKD, several treatments are considered to be beneficial, including blood pressure control, exercise, low-salt diet, and high volume water intake. However, levels of understanding of the importance of these treatments and adherence to these recommendations vary among patients. This study explores illness perception models of patients with PKD to reveal barriers in adherence to prescribed therapies; satisfaction with medical care; and sources of medical information. METHODS: We designed a phenomenological interview study to evaluate illness perception models of individuals with PKD. Patients were identified from the national PKD Foundation e-mail distribution list (N = 190) and responded voluntarily to an introductory survey (N = 50). Seventeen PKD patients in the Bay Area were scheduled for one-on-one in-depth interviews with one trained interviewer (W-CT). Open-ended questions administered with an interview guide were used to evaluate patients’ beliefs. RESULTS: Mean age was 56.6 +/− 12 years (range 29–78); 65% were female. Many of the PKD patients in this study were highly motivated and willing to incorporate blood pressure, exercise, low-salt diet, and high volume water intake into their daily routines. Barriers to adherence to these therapies include personal beliefs and confusion due to unclear recommendations. CONCLUSIONS: These findings suggest there is variability between what patients understand about their disease and treatments and what they believe their doctors have told them. Not all physicians focus on lifestyle-based treatments, but the majority of PKD patients in our study are motivated and willing to incorporate blood pressure control, exercise, low-salt diet, and high volume water intake into their daily routines and would like specific recommendations on how to implement these. These findings support a role for further exploring patient beliefs about the disease and its necessary treatments in order to design strategies to improve communication and meet the needs of these patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12882-017-0641-3) contains supplementary material, which is available to authorized users. BioMed Central 2017-07-05 /pmc/articles/PMC5498983/ /pubmed/28679364 http://dx.doi.org/10.1186/s12882-017-0641-3 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Tran, Wen-Ching Huynh, David Chan, Tea Chesla, Catherine A. Park, Meyeon Understanding barriers to medication, dietary, and lifestyle treatments prescribed in polycystic kidney disease |
title | Understanding barriers to medication, dietary, and lifestyle treatments prescribed in polycystic kidney disease |
title_full | Understanding barriers to medication, dietary, and lifestyle treatments prescribed in polycystic kidney disease |
title_fullStr | Understanding barriers to medication, dietary, and lifestyle treatments prescribed in polycystic kidney disease |
title_full_unstemmed | Understanding barriers to medication, dietary, and lifestyle treatments prescribed in polycystic kidney disease |
title_short | Understanding barriers to medication, dietary, and lifestyle treatments prescribed in polycystic kidney disease |
title_sort | understanding barriers to medication, dietary, and lifestyle treatments prescribed in polycystic kidney disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498983/ https://www.ncbi.nlm.nih.gov/pubmed/28679364 http://dx.doi.org/10.1186/s12882-017-0641-3 |
work_keys_str_mv | AT tranwenching understandingbarrierstomedicationdietaryandlifestyletreatmentsprescribedinpolycystickidneydisease AT huynhdavid understandingbarrierstomedicationdietaryandlifestyletreatmentsprescribedinpolycystickidneydisease AT chantea understandingbarrierstomedicationdietaryandlifestyletreatmentsprescribedinpolycystickidneydisease AT cheslacatherinea understandingbarrierstomedicationdietaryandlifestyletreatmentsprescribedinpolycystickidneydisease AT parkmeyeon understandingbarrierstomedicationdietaryandlifestyletreatmentsprescribedinpolycystickidneydisease |